Advances in the treatment of atherosclerosis with ligand-modified nanocarriers
Overview diagram of targeted ligand-modified nanomedicines for the treatment of atherosclerosis. Ligand-modified nanoparticles targeting specific atherosclerosis receptors at each pathological stage from monocyte recruitment, macrophage polarisation and foam cell formation, vascular smooth muscle cell phenotypic transformation, and vulnerable plaque formation, opening up ideas for the design of atherosclerosis-targeted nanomedicines. Abstract: Atherosclerosis, a chronic disease associated …
Advances in the treatment of atherosclerosis with ligand-modified nanocarriers Read More »









